Our primary and key secondary objectives were to investigate whether indacaterol was non-inferior to tiotropium for trough forced expiratory volume in @ s ( FEV@ ) at week @ ( primary endpoint ) , and for rate of exacerbations at week @ ( secondary endpoint ) .